Evaluation of combined oncological and functional outcomes after radical prostatectomy: trifecta rate of achieving continence, potency and cancer control--a literature review.
The first objective of radical prostatectomy is cancer control. However, the success of RP should be also measured by the long-term morbidity outcomes and by the maintenance of quality of life. We performed a review of the literature for combined results of continence, erectile function, and cancer control after radical prostatectomy. Since 2003 and the first report of "trifecta," only 7 series have yet reported such combined results (trifecta rate range: 20%-76%). The preoperative risk (D'Amico) predicted for quality of life outcomes and biochemical recurrence is an aggregate endpoint, the trifecta.
Xylinas
Evanguelos
E
INSERM, Unit 955 EQ7, Department of Urology APHP, CHU Henri Mondor, Créteil, France.
Ploussard
Guillaume
G
Durand
Xavier
X
de La Taille
Alexandre
A
Gillion
Norman
N
Allory
Yves
Y
Vordos
Dimitri
D
Hoznek
Andras
A
Abbou
Claude Clément
CC
Salomon
Laurent
L
D006801:Humans; D008297:Male; D010410:Penile Erection; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000097:blood / Q000601:surgery*; D011788:Quality of Life; D016896:Treatment Outcome; D014554:Urination
D017430:Prostate-Specific Antigen